BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
Apoptosis
,
Lung cancer
,
Intestine
,
Alcohol
,
Rapamycin
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ccl2 protein
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
CCL2 rs1024611Gene Polymorphism in Philadelphia-Negative Myeloproliferative Neoplasms.
Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression.
Microglia-derived CCL2 has a prime role in neocortex neuroinflammation.
CCL2 Inhibition of Pro-Resolving Mediators Potentiates Neuroinflammation in Astrocytes.
CCL2 in the Tumor Microenvironment.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in P…
Anabolic Effects of Whey and Casein After Strength Training in Young and Elderly
The Effects of Bindarit in Diabetic Nephropathy
A Phase I Clinical Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ